Skip to main content

Market Overview

Aprea Therapeutics Opens Above IPO Price


Aprea Therapeutics, Inc. (NASDAQ: APRE) made its public debut Thursday morning, opening at $15.46 after being priced at $15 per share.

The shares are listed on the Nasdaq under the ticker symbol “APRE.”

Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53.

JPMorgan, Morgan Stanley and RBC Capital Markets are acting as joint book-running managers for the offering.

Related Links:

IGM Biosciences Opens Above IPO Price

Ping Identity Holding Opens Above IPO Price


Related Articles (APRE)

View Comments and Join the Discussion!

Posted-In: News IPOs

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at